explore
Previous article:
Novavax promises a turnaround & Lilly roils the obesity market
Next article: Medicare Advantage insurers face 0.2% cut to 2025 payments
Next article: Medicare Advantage insurers face 0.2% cut to 2025 payments
hotspot
focus
-
ASCO: AstraZeneca says CAR
2025-09-27 23:47 -
Medicare drug price negotiation legal challenge met with skepticism
2025-09-27 23:42 -
ASCO: AstraZeneca says CAR
2025-09-27 23:38 -
At ASCO, pharma leaders speak of advances in 'smart bomb' drugs
2025-09-27 23:03 -
Readout LOUD podcast: ASCO preview, a Duchenne trial failure
2025-09-27 21:10 -
Wegovy leads to weight loss. Can it treat depression, too?
2025-09-27 21:06